Combining Tal-PDT with PD-1 inhibitors showed synergistic abscopal effects, with activation of conventional type I dendritic cells (cDC1s) in the proximal dLN and generation of replicable precursor-exhausted T cells (Tpex cells) in the distal tumor sites. Here, PDCD1 is linked to neoplasm.